Damon Harrell
About Damon Harrell
Damon Harrell is the Vice President and General Manager of the Psychiatry Franchise at Alkermes, overseeing the marketing and sales of treatments for schizophrenia and bipolar-1 disorder.
Title: Vice President and General Manager at Alkermes
Damon Harrell holds the position of Vice President and General Manager in the Psychiatry Franchise at Alkermes. Based in Waltham, Massachusetts, he operates in a hybrid work model. In this role, he oversees the marketing and sales of significant pharmaceutical products, including ARISTADA, a long-acting injectable for schizophrenia treatment, and LYBALVI, an oral treatment for schizophrenia and bipolar-1 disorder.
Previous Experience at Alkermes
Before his current role, Damon Harrell served as Vice President of Marketing for the Psychiatry Franchise at Alkermes from 2019 to 2023. During his tenure, he contributed significantly to the company's strategies and operations in the Greater Boston Area. His efforts focused on enhancing execution, fostering cross-functional collaboration, and optimizing resource allocation within the Psychiatry Franchise.
Career at Merck Sharp & Dohme
Damon Harrell began his career at Merck Sharp & Dohme, where he held multiple positions over several years. He was the Global Strategy lead for Anesthesia from 2010 to 2013. Prior to that, he managed the Cardiovascular Franchise from 2007 to 2010. He also worked on Managed Care Strategy from 2005 to 2007, gaining comprehensive experience in various aspects of pharmaceutical marketing and strategy.
Education: MBA from The Wharton School
Damon Harrell earned his Master of Business Administration (MBA) from The Wharton School, University of Pennsylvania, between 2001 and 2003. This advanced education provided him with the skills and knowledge essential for leadership roles in the pharmaceutical industry. He also studied at the University of Wisconsin-Madison, which laid the foundation for his professional career.
Role in Psychiatry Franchise Leadership
In his role at Alkermes, Damon Harrell is responsible for key opinion leader identification and thought leader development in psychiatry. He assumed this newly created position in the Psychiatry Franchise leadership model to boost execution, foster collaboration, and enhance decision-making within the company. His broad commercial experience and previous contributions have positioned him well for this leadership role.